EXAMINING THE EXPRESSION AND CORRELATION OF TRIP13 AND ANGPT1 IN SMALL CELL LUNG CANCER: A PROFESSIONAL EXPLORATION WITH AN ANALOGY TO FOOTBALL PLAYERS

Abstract

This professional exploration delves into the intricate realm of thyroid hormone receptor interactor 13 (TRIP13) and angiopoietin-1 (ANGPT1) within the context of small cell lung cancer (SCLC). Drawing parallels to the precision and teamwork exemplified by football players on the field, we meticulously investigate the expression patterns and correlations of these molecular players in the complex landscape of SCLC. Our study encompassed a cohort of 78 SCLC patients treated at our institution between January 2015 and April 2017. Through rigorous immunohistochemical staining, we scrutinized the expression profiles of TRIP13 and ANGPT1 within tumor tissues, seeking to unravel their associations with clinicopathological characteristics and progression-free survival. Noteworthy findings emerged from our analysis. We observed significantly elevated positive expression rates of TRIP13 in SCLC tissues with lower differentiation levels and liver metastases, highlighting the analogy to football players' precise maneuvers. Similarly, ANGPT1 exhibited markedly increased positive expression rates in cases with larger tumor diameters, lower differentiation, and liver metastases, akin to a coordinated football team's collective effort. Our professional exploration uncovered a compelling positive correlation between the expression levels of TRIP13 and ANGPT1 in SCLC, akin to the synergy seen among football players on the field. This molecular partnership shed light on an intriguing aspect of SCLC's pathophysiology. The impact on progression-free survival time further emphasized the clinical relevance of TRIP13 and ANGPT1 in SCLC. Patients expressing both TRIP13 and ANGPT1 or either molecule alone experienced significantly shorter mean progression-free survival times, akin to the swift tactics and strategies employed by football players in a high-stakes game